Riskpilot← Back to searchSign inGet full accessMARCOPOX EPOXIGOLV AB
ABActiveOrg 5565847737Floor and wall covering · NACE 4333Est. 20000 employees
Revenue 2025
SEK 0
EBITDA margin
—
-36% vs 2024
Equity ratio
99.6%
Financial strength
Net profit 2025
SEK 59K
+76% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -17K | -36% |
| Net profit | SEK 59K | +76% |
| Total assets | SEK 2,9M | -5% |
| Equity | SEK 2,8M | -5% |
| Employees | 0 | — |
Legal name
MARCOPOX EPOXIGOLV AB
Org number
5565847737
Legal form
Aktiebolag
NACE code
4333 · Floor and wall covering
Founded
4 februari 2000
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utföra golv- och väggbeläggningsarbeten och därmed förenlig verksamhet.
Address
Phone
+4640964950
Email
ankan_00@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 58 | −14 | −11 | −12 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 58 | −14 | −11 | −12 | −17 |
| Net financials | 374 | — | — | 46 | 76 |
| Profit before tax | 432 | −14 | −11 | 34 | 59 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | 432 | −14 | −11 | 34 | 59 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 052 | 3 482 | 3 169 | 3 019 | 2 858 |
| Equity | 3 988 | 3 474 | 3 163 | 3 012 | 2 847 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 64 | 8 | 6 | 7 | 11 |
| Total debt | 64 | 8 | 6 | 7 | 11 |
EBITDA margin
-1697100.0%
This company
15.8%
Market median
-10741239% vs market
20212025
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
5929000.0%
This company
8.1%
Market median
+73197431% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MARCOPOX EPOXIGOLV AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per-Åke Stefan Persson | Deputy Board Member | 0 companies |
| Annica Heléna Persson | Board of Directors | 0 companies |
| Marek Kozlowski | Board of Directors | 0 companies |